| GEN – Genetic Engineering and Biotechnology News
Artificial intelligence can detect one of the most common forms of blood cancer – acute myeloid leukemia (AML) – with high reliability
Artificial intelligence can detect one of the most common forms of blood cancer – acute myeloid leukemia (AML) – with high reliability
An AI method offers a new way to understand protein structures in multiple dimensions and may be a useful tool for pharmacology.
The study showed that DNA damage in response to stimuli triggers an inflammation pathway that prompts activity in memory-encoding neurons.
Lonza’s new offering provides manufacturing of spray-dried protein formulations, nucleotide-based drugs, and peptides.
Depleting myeloid-biased HSCs in aged mice restored features of a more youthful immune system, while reducing age-related markers of immune decline
Synthego announced that it will focus solely on the therapeutic applications of CRISPR while spinning off a new company, EditCo Bio, which is positioned to…
Phase I/IIa data for a single dose of REGENEXBIO’s gene therapy, RGX-314, shows promise for treating wet age-related macular degeneration.
Biotech news and conversation from the editors of Genetic Engineering & Biotechnology News
The landscape of novel monoclonal antibody (mAb) therapeutic formats has expanded significantly in recent years, introducing new challenges in the purification process. Traditional full-length IgG…
The study showed that DNA damage in response to stimuli triggers an inflammation pathway that prompts activity in memory-encoding neurons.
Depleting myeloid-biased HSCs in aged mice restored features of a more youthful immune system, while reducing age-related markers of immune decline